Baseline predictors of being exacerbation-free during 2 years of benralizumab treatment

John W. Upham, David J. Jackson, Peter Barker, Paul Newbold, William Cook

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	European Respiratory Journal
Volume	54
DOIs	https://doi.org/10.1183/13993003.congress-2019.OA5337
Publication status	Published - 28 Sept 2019

Keywords

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{f2beac8094684d4aab6835e39f537297,

title = "Baseline predictors of being exacerbation-free during 2 years of benralizumab treatment",

keywords = "Asthma - management, Treatments, Exacerbation",

author = "Upham, {John W.} and Jackson, {David J.} and Peter Barker and Paul Newbold and William Cook",

year = "2019",

month = sep,

day = "28",

doi = "10.1183/13993003.congress-2019.OA5337",

language = "English",

volume = "54",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

}

TY - JOUR

T1 - Baseline predictors of being exacerbation-free during 2 years of benralizumab treatment

AU - Upham, John W.

AU - Jackson, David J.

AU - Barker, Peter

AU - Newbold, Paul

AU - Cook, William

PY - 2019/9/28

Y1 - 2019/9/28

KW - Asthma - management

KW - Treatments

KW - Exacerbation

U2 - 10.1183/13993003.congress-2019.OA5337

DO - 10.1183/13993003.congress-2019.OA5337

M3 - Meeting Abstract

SN - 0903-1936

VL - 54

JO - European Respiratory Journal

JF - European Respiratory Journal

ER -